ABSTRACT. We examined the effect of continuous sc infu· sion of a GnRH agonist (Ag) and testosterone (T) supp~emen· tation on spermatogenesis and the pvtential fertilizing capacity of sperm in 15 rhesus monkeys. The monkeys were divided into 3 groups of 5 animals each. Groups 1 and 2 received 25 Ilg/day Ag for 44 weeks. Group 2 also received T replacement therapy Isufficient to maintain serum T values within the normal range; 4-5 ng/mL (13.9-17.3 nmol/L)J. Group 3 received alow dose of the Ag (5 Ilg/day for 24 weeks and then 10 Ilg/day for 20 weeks) to prolong the oligospermic phase before the onset of azoosper· mia. In groups 1 and 3, there was an initial transient (l week) rise in serum LH and T levels which t hen fell below pretreatment values, where they remained throughout the treatment period. The serum LH and T levels were lower in the group treated with 2;) JIg/day Ag. Similar changes in serum LH levels occurred in group 2, hut T supplementation maintainer! serum T in the physiological range. The decline in serum LH levels was associ· ated with reduc.:!d sensitivity to GnRH, since the responses of serum LH and T to GnRH were either abolished or greatly reduced in the 2 groups treated with 25 Ilg/day Ag and were less than 50% of the pre·Ag responses in monlleys treated with 5-10 leg/day Ag.
T supplementation became Ilzoospermic (mean time to onset, 12.6 weeks). Four of five monkeys treatec with 5-10 Ilg/day Ag also had azoospermic ~jaculates during the late treatment and early recovery period. Sperm counts recovered to the pretreat· ment levels in most monkeys by 10 weeks of the recovery period. The quc.lity of semen samples taken from oligospermic mon~eys was greatly reduced. The percentage of motile and percentage of live sperm per ejaculate, the net negative wrface charge on s;>erm, and the scores of sperm in the hamster oocyte penetration test were subnormal. T supplementation did not improve these measures of seme'l quality. Testicular biopsies taken at the end of the Ag administration period from monkeys given 25 Ilc/day Ag showed diffuse atrophy of the seminiferous tubules, which contained primarily Sertoli cells and a few spermatogonia and spermatocytes, but no spermatids. The tubular atrophy and the suppression of spermatogenesis did not appear tc.. be inf1uenc~d by T replacement. These results do not. support the conclusion of o'.her investigators that T supplementation in the Ag·treated monkey prevents the induction of azoospermia. The data suggest that GnRH analog administration, combined with androgen therapy to maintain libido and potency, may he an acceptable method of male contraception, (J Clin Endocrinol Metab 65: 1215 , 1987 Combined treatment induced oligospermia in 8-10 weeks, but azoospermia was not achieved by 22 weeks. Moreover, the decline in testicular volume associated wit.h Ag administration was postponed by T therapy (4) . In the context of male contraception, these results suggested that T administration could begin only after azoospermia was achieved, and they thus raised import.ant questions about the feasibility of using GnRH anaJogs for male contraception.
In men Ag administration not only greatly reduces serum T levels but also causes symptoms of l:ypogonadism (hot flushes, loss oflibido and potency) (5) . Androgen therapy is necessary to maintain libido and potency. ' 
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Combined Ag and androgen treatment of six men for 20 weeks caused oligospermia, but not azoospermia (6) . On the other hand, T administration potentiated the inhibitory effect of Ag in rats (7, 8) . These conflicting data and the need for androgen replacement during Ag-induced infertility made it important to reexamine whether combined Ag and T admii1istration would induce azoospermia in the primate. In this study, therefore, we tested the effect of administration of Ag with and without T replacement t.herapy on reproductive function in monkeys. A second objective of this study was to determine the potential fertilizing capacity of sperm from Agtreated oligospermic monkeys, since we recently found that sperm that appeared normal in morphology and motility from GnRH antagonist-treated animals may have reduced fertilizing potential (2).
Materials and Methods
Fifteen adult male monkeys (Macaca mulatta), ranging in weight from 6.7-10.9 kg and housed singly in a controlled environment (temperatllre, 20-23 C; lighting schedule, 12 h of light. 12 h of dark). were used in this study.
Treatment groups
The 15 monkeys were randomly assigned to one of three treatment groups of five animals each. Animals in group 1 were treated with 25 I-/g/dr,y Ag (D-Trp6-N-a-Me-Leu 7 -des GIyJ()_ Pr0 9 ·NH EtGnRH; Wy-40972. Wyeth Laboratories. Philadelphia. PAl for 44 weeks using Alzet osmotic minipumps (2ml-4, Alza Corp .
• Palo Alto, CAl. Those in group 2 were treated simultaneously with 25 GnRH Ag. and T was administered using a sc implanted 5·cm long Silastic elastomere (od. 0.465 rm: in, 0.335 em). One elastomere of T was implanted in each animnl. Group 3 received [, I-/g/day Ag for 24 weeks and then 10 I-/g/dny Ag for an additional 20 weeks using minipumps. These low Ag dosages were chosen to produce prolonged oligospermiu before the onset of azoospermia. so that the potential fertilizing capacit.y of recovered sperm could be more fully assessed.
Surgical implantation 0.' minipumps and T elastomers
Animals were anesl.hetized with 10 mg/kg BW ketamine HCI, and the minip11mps and T capsules were implanted sc in the interscapular region under sterile conditions. Minipumps containing the appropriate Ag concentration dissolved in sterile water were replaced every 28 days, and T implants were replaced at 16-week intervals. The residual Ag volume in each minipump was measured when it was removed. The mean residual volume was 0 .. ~<1 ± 0.01 (SEM) mL. This vQ)ume did not differ significantly between treatment groups or individual animals.
Blood and semen sampling .~chedule
Blood samples were taken at weeldy intervals during a 5-week control period, on treatment. days 2 and 7. and then weekly throughout the 44-week Ag administration and the 20-week recovery periods.
Semen samples were collected by penile electrostimulativn. Three to five semen samples were collected from each animal during the control period and at 2-week intervals during the Ag administration and recovery periods for determination of sperm counts, percentage of motile sperm, and percentage of live sperm.
Net surface charge on sperm
Sperm samples were washed, fixed in 2% glutaraldehyde, and exposed to colloidal iron on carbon plates. as previously dE-scribed (9) . The specimens were examined !It 25 kV at a 35" takeoff angle in an lSI DS 130 scanning electron microscope (International Scientific Inst., Miltit!ls, CAl. The energy dispersive x-ray spt!ctra of the sperm head were obtained using a Tracor Northern 5500 analyser. The energy spectrum of the )Crays emitted. characteristic of an element, was used to identify the clements present. The peaks derived from Na (1.041 keV), P (2.015 keV). S (2.308 keV), CI (2.622 keV), Ca (3.691 keV), and Fe (6.403 keV) were quantitated, and the background was subtracted. Thus, the integrals were expressed as a percentage of Fe counts relative to these of the other elements (Fe/Na. p.
K. CI, S, Ca X 100). Duplicate samples were analyzed, and 100 sperm were measured in each sample.
Hamster ova penetration assay (SPA)
The SPA was performed basically as described prevIOusly (l0) on sperm samples taken during the control period; at 3-10. 11-15, and 16-44 weeks of Ag administration; and at 20 and 25 weeks during the recovery period. The original method was modified by the use of Dulbecco's medium during preparatio., of the oocytes and by extending the incubation time beforl! reading the assay results. Briefly. oocytes were recovered from superovulated hamsters (25 IU PMSG, ip, followed by 50 Ilf hCG, ip. 3 days later), the cumulus cells were removed by incubation in 1 % hyaluronidase for 15 min, and the zonae were dissolved by transferring the oocytes to a 0.1 % trypsin solution in Dulbecco's medium for 10 min. After the zonae were dissolved. the denuded oocytes were transferred to Ham's F-I0 medium containing 10% human cord serum. After washing, 10-30 oocytes were incubated in 0.5 mL culture medium in an 8-well culture slide; each well had a volume of 0.6 mL. The oocytes were incubated with 25,000 motile sperm/oocyte in 5% CO2 in air at 37 C for 17 h. Semen sample!:! were washed twice in Ham's F-I0 medium, concentrated by centrifugation, and subjected to the "swim up" technique before incubation with oocytes. The assay was scored according to the percentage of oocytes penetrated per well.
Pituitary and testicular responses to GnRH
During the control period and at <1 -week intervals throughout Ag administration and recovery periods, animals were anesthetized with 10 mg/kg BW ketamine HCI and injected iv With 25 I-/g GnRH. Blood samples were taken at 15 and 0 before and 15,30, 60. and 120 min after GnRH administration for LH and T determinations.
Testicular volumes and biopsies
Testicular volume was determined at monthly intervals, as previously described (2) . Testicular needle biopsies were performed on OnE, testis f,'om each animal during the control period and on the alternate testis at the termination of Ag administration for routine histological examination, as previously described (2) .
Assays for LH and T
Serum LH concentrations were measured in duplicate using the mouse interstitial T-cell bioassay (l :). The NIDDK rhesus monkey pituitary gonadotropin standard (LER-1909-2) was used as the reference preparation. The intra-and interassay coefficients of variation for the LH assay were 7.3% and 19.3% for a serum pool containing 2.0 J.lg/mL LH. The coefficients of variation did not differ significandy over the usable portion of the LH stand~\rd curve (0.2-10 J.lg/mL). The sensitivity of the LH assay was 0.2 J.lg/mL. Serum T concentrations were measured in duplicate by RIA, as previously described (12) . The intra-and intcrnssay coefficients of variation for the T assay were 4.9% and 6.8%, respectively, for a serum pool containing 5 ng/mL T. The sensitivity of the T assay was 0.5 ng/mL.
Statistics
The data were evaluated using either analysis of variance 0,' :/ test (SPA, frequency of elcctroejaculation).
Results
Animals in group 1 were given 25 J.Lg/day Ag for 44 weeks. The animals in group 2 were treated simultaneously with 25 pg/day Ag and T for 44 weeks, and the group 3 animals were given 5 J.Lg/day Ag for 24 weeks, then 10 J.Lg/day Ag for an additional 20 weeks.
Serum LH and T concentrations
Serum LH levels .ose initially and then fell precipitously to near-minimal levels of detection (0.2 J.Lg/mL) in four of the five monkeys in group 1 (Fig. lA, top) . In these four monkeys, the serum LH levels then remained below the control levels through the remainder of the Ag administration period. The fifth animal (no. 4960; data not included in Fig. 1 ) was less sensitive to the Ag. The pattern of change in serum LH concentrations was similar, but the LH values remained near-control values during the last 40 weeks of Ag administration. Serum T values in the four responsive monkeys rose from control values between 4 and 8 ng/mL (13.9-27.7 nmol/L) to 39.7 ± 5.6 (±SEM) ng/mL (138 ± 19 nmol/L) on'day 2, and then declined to near-castrate values «0.70 ng/mL; 2.4 nmol/L; Fig. lA, bottom) . The fifth animal (no. 4960) had normal serum T levels after the initial increase. In the group 2 monkeys, the changes in serum LH were similar to those in the four responsive monkeys in group 1. The senlm T pattern was similar, except serum T did not fall to castrate values, but was maintained between 4-·5 ng/mL (13.9-17.3 nmol/L) by the sc T implants (Fig.  IB) . The monkeys in group 3 had an initial rise in serum LH and T levels similar to that. ill group 1 (Fig. Ie) , but there was less suppression of serum LH and T levels thereafter.
Serum LH and T concentrations increased soon after the termination of Ag administration and were similar to pretreat.ment values within 10-12 weeks (Fig. 1) . Serum LH and T levels were supranormal for 10 weeks in groups 1 and 2 ( 
Pituitary and testicular responses to GnRH
The serum LH and T responses to 25 J.Lg GnRH were abolished in four of the five monkeys in group 1 and the five animals in group 2 (Fig. 2) . The remaining animal (no. 4960) in grnup 1 had significant, but reduced, serum LH and T responses to GnRH administration throughout the Ag administration period (data not shown). In the animals in group 3, the peak serum LH and T responses to GnRH were reduced to less than 30% of the control responses by 36 weeks (Fig. 2) . The serum LH and T responses to GnRH had returned to the control levels in all groups within 8 weeks after the discontinuation of Ag.
Testicu!ar volumes
There was a significant effect of time (P < 0.005) and a significant interaction (P < 0.05) of the two variables (time x treatment) on testicular volume. An initial small increase in testicular volumes was found after 2 weeks of Ag administrat.ion, followed by a rapid decline to a plateau after 10 weeks in all three groups (Fig. 3) . The decline (44%) was less marked in group 3 animals than in those in group 1 (71 %) or group 2 (73 %). Thus, T administration did not alter the Ag-induced decline in testicular volume. The data in Fig. 3 do not include the monkey (no. 4960) that was less sensitive to Ag. This monkey had only a minimal decrease in testicular volume during Ag administration.
Semen analysis
During the pretreatment period the success rate of electroejacuiation ranged between 94-95% for the three groups of monkeys. This rate declined in all three groups during the treatment period (Table 1) . However, only one of the animals treated simultaneously with Ag and T (group 2) had a reduced frequency of ejaculation. This occurred after 27 weeks of treatment. Figure 4 illustrates the effect of Ag administration on mean sperm counts in the three groups. Four of five animals in group 1 became azoospermic after 11-21 weeks of Ag administration (Fig. 4, top) . It was difficult to determine exactly wnen azoospermia was achieved in this group because two of the monkeys did not have a consistent ejaculatvry response before the onset of azo-('spermia. The fifth animal (no. 4960) in this group never had azoospermia, although one azoospermic sample was collected during the recovery period. All five monkeys in group 2 became azoospermic after 16 weeks (mean, 12.6 ± 1.2 (±SEM) weeks], and four of the monkeys consistently had azoospermic ejaculates for the remainder of the treatment period (Fig. 4, middle) . The fifth animal had no ejaculatory response between weeks 27 of treatmen~ and week 1 of the recovery period. His ejaculates were azoospermic for 12 weeks before and 4 weeks after this loss of ejaculatory response. After azoospermia was achieved in the monkeys in group 2, there were a few occasions (one or two per monkey) when ejaculates had a small number of sperm «6% of the control level). These ejaculates were of reduced volume «10% of nor111al) and contained a subnormal number of live sperm «30%).
In eight of the nine monkeys in gTOl1PS 1 and 2 who achieved azoospermia, azoospermia persisted for 7 weeks after the termination of Ag (Fig. 4) . After that, sperm counts in all but one animal returned quickly to control levels. The remaining monkey was unresponsive to penile electrostimulation between weeks 8 and 16 of the recovery period. An ejaculate collected during recovery week 17 using the rectal probe electroejaculatory technique contained a normal sperm number (2.4 X lOB million/ mL) and normal percentages of motile and live sperm. Figure 4 (bottom) shews the mean sperm counts in the five monkeys in group 3. Mean sperm counts were lower than control h:vds during the latter part of Ag administration and early in the recovery period, and ejaculates with no sperm were recovered from four of five monkeys in this group during these times.
Group 1 and group 2 animals had mean percentages of motile sperm of 87.1 ± 1.9% (±SEM) and 81.9 ± 1.9%, respectively, and mean percentages of live sperm of 9004 ± 1.6% (±SEM) and 87.6 ± 1.1:.%, respectively, during the control period. In the two ejaculates immediately preceding the onset of azoospermia, the percentages of motile and live sperm in the two groups were 38.7 ± 9.4% and 42.5 ± 10.5% (P < 0.001) and 53.0 ± 8.9% and 47.2 ± 9.3% (P < 0.001), respectively. Monkeys in group 3 also had a reduction in the percentages of motile (P < 0.01) and live sperm (P < 0.01) in ejaculates during the iast 12 weeks of the treatment period (mean percentage of motik C::!lerm: control, 81.9 ± 2.3%; Ag administration, 53.5 ± 9.5~; mean percentage of live sperm: control, 88.5 ± 1.5%; Ag administration, 54.0 ± 9.1 %).
The effect of Ag administration on the percentage of hamster oocytes penetrated by sperm from individual monkeys in the 3 treatment groups is shown in Fig. 5 . Semen samples from groups 1 and 2 during treatment weeks 11-44 showed a reduced ability to penetrate hamst.er oocytes compared to control samples (by x 2 , P < 0.05 for group 1 and P < 0.005 for group 2). Overall, there was no significant change in the SPA for group 3.
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The SPA was performed on semen samples from all monkeys again at 20 weeks of the recovery period. By that time, sperm samples from 8 of 10 monkeys in groups 1 and 2 had a normal penetration score. The 2 monkeys with a subnormal SPA score at 20 weeks of recovery were retested 5 weeks later and had a normal SPA score.
There was an unimodal distribution of net llegative surface charge on rhesus monkey sperm (Fig. 6) . 
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• Significantly different from the pretreatment value, P < 0.025. b Significantly different from the pretreatment value, P < 0.005. , Significantly different from the pretreatment valllr, P < 0.005.
d Significcntly different from the pretreatment value, P < 0.05.
, Significantly different from the pretreatment value, P < 0.005.
charge on sperm in all three treatment groups. In animals in group 3, the percentage of iron on the surface declined from a control level of 48.8 ± 4.4% to 27.4 ± 2.1 % (P < 0.001), compared to a decrease from 45.8 ± 2.2% and 51.7 ± 2.6% to 33.9 ± 4.5% (P = 0.045) and 33.0 ± 3.2%
(P = 0.001) in groups 1 and 2, respectively. T maintenance therapy did not Alter the effect of Ag on the net surface charge on sperm.
Testicular histology
Animals in groups 1 and 2 had severe hypospermatogenesis after 44 weeks of Ag administration comparable to that previously reported after short term (20 week) treatment with the same GnRH analog (2) . While the degree of inhibition of spermatogenesis varied from mon- (Fig. 7) . Testicular histology from the one monkey in group 1 who did not become azoospermic revealed normal tubular cellularity and active spermatogenesis with progression IZ2J -..
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. . . . to the late spermatid stage in almost all tubules. Animals in rrroup 3 had a less severe suppression of spermatogenesis. Tubules from these animals had reduced levels of spermatogenesis, with the most prominent. stages being spermatocytes and early spermatids, and only a few late stage spermatids. One animal in this group had suppression of spermatogenesis c:omparable to that in monkeys in groups 1 and 2.
In all groups, there was severe atrophy of the seminiferous tubules. Tubular diameters declined 46% (P < 0.001) in group 1,53% (P < 0.001) in group 2, and 35% (P < 0.025) in group 3. the percentage total of sperm counted (lOO/sample). The surface charge on sperm was measured on 17 samples from 9 monkeys during the control period and again on 26 samples between 5 and 10 weeks of administration of 25 /lg/day Ag (group 1; n = 11 samples from 3 mono keys), 25 /lg/day Ag and T (group 2; n '" 8 samples from 3 monkeys), and 5 /lg/ day Ag (group :J; n = 7 samples from 3 monkeys).
Body weight
Body weights did not change In any of the three treatment groups.
Discussion
The results of this st~dy clearly show that azoospermia can be induced in rhesus monkeys treated with 25 JIg/ day Ag and simultaneously given T to maintain the ejaculatory response. T administration did not attenuate the response to the analog, as reported previously (3, 4) . Monkeys treated with Ag and T exhibited desensitization of the pituitary to GnRH and a decline in serum LH values to near-minimal levels of detection as rapidly as animals treated with Ag alone. Moreover, the rate of decrease and the lower testicular volume achieved during Ag treatment were not affected by T administration. Azoospermia occurred in all animals treated with Ag by 16 weeks (mean, 12.6). It was not possible to compare the time of onset of azoospermia with that in animals treated only wit.h 25 JIg/day Ag, because two of the four monkeys that became azoospermic in the latter group also had a decreased sensitivity to electrocjaculation before their first azoospermic ejaculate. However, dll four ar,imals in this group were azoospermic by 21 weeks of treatment, suggesting that the times of onset of azoospermia were similar in animals treated with 25 JIg/day Ag alone or with T. Thus, our data do not support the conclusion of other investigators (3, 4) that the administration of physiological doses of T to maintain libido and potency interferes with the induction of azoospermia with a GnRH analog.
The reason for the discrepancy between these and previous results in monkeys (3, 4) is not readily apparent. Ag administration was terminated at 22 weeks in the previous study, so azoospermia might have been achieved [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] PEACtNT FE SHiO 61-70
if the treatment period had been prolonged. However, all five monkeys treated witil Ag and T in our study were azoospermic by 16 weeks. T administration reinitiates spermatogenesis in pituitary stalk-sectioned monkeys and stimulates spermatogenesis in immature monkeys (13, 14) . However, the circulating T levels needed to initiate spermatogenesis were 10-to 20-fold higher than those found to maintain the ejaculatory response in our study and the previous report (3). Moreover, circulating T concentrations were comparable in the two studies (3). Thus, differences in maintenance doses of T may not account for the conflicting results. One major difference between the two studies is the use of different Ags.
One of the monkeys treated with 25 ,ug/day Ag alone never became azoospermic. Moreover, the pituituty uf this animal continued to show significant, although reduced, serum LH and T responses to GnRH. We have treated 18 male monkeys with 25 JIgjday Ag; this is the first animal that had a reduced response to this analog. In fact, 4 of 5 monkeys treated with first 5 then 10 JIg/ day Ag in this study had a number of azoospermic ejaculates during the late treatment and early recovery periods. We have no explanation for the apparent insensitivity of this 1 animal to the analog. It is unlikely that minipump malfunction explains the failure of this monkey to respond, since residual volumes of Ag remaining when the minipumps were removed did not vary significantly from pump to pump.
Earlier data frum clinical trials in humans suggested that it might not be possible to induce azoospermia with Ag (5, 6, 15, 16) . However, these studies were of limited duration (10-20 weeks) , and except for the third study, the agonist was administered by daily sc injection, a method less effective than continuous administration (4, 17) . In all of these studies, oligospermia, but not azoospermia, was achieved. Two recent reports (18, 19) offer more hope for this contraceptive approach. Bouchard et al. (18) treated two groups of five men each with the DTrpu-GnRH agonist injected sc in biodegradable microspheres that released 100 Jlg agonistjday. One group received low dose androgen replacement sufficient to maintain serum T levels in the 1-3 ng/mL (3.5-10.4 nmoIjL) range. A second group received a higher dose that maintained T values in the 2-5 ngjmL (6.9-17.3 nmoljL) range. Androgen therapy was begun 40 days after the beginning of agonist treatment. Four of th€ five men in the first group (low dose of T) became azoospermic by 28 weeks, while azoospermia was not achieved in the second group even though treatment was continued for 35 weeks. Swerdloff et al. (19) found that 400 Jlgjday of an agonist given by constant infusion plus 200 mg T enur.t hate given by im injection every 2 weeks resulted in azo\)spermia in three of seven men. These results suggest that azoospermia can be achieved in men with GnTi}' analog administration even if androgen replacement is provided to maintain libido. The dose of androgen may be important in determining whether azoospermia can be obtained while maintaining libido and potency.
One of the monkeys in our study had refractiveness to electroejaculation despite 'I:' replacement during the late treatment period (weeks 27-44). We have previously shown that continuous administration of Ag in monkeys is not only associated with a reduction of basal T Eecretion, but also abolishes the nocturnal rise in serum T (17) . The maintenance dose of T used in this study was based on mean morning serum T levelf'. during the pretreatment period. These levels ~ay be less than the mean 24-h value and may not be sufficient to maintain the ejaculatory response. The critical aspect of T in maintaining spermatogenesis in primates and rodents is the intratesticular concentration (13, 14, (20) (21) (22) . While as little as 10-20% of the normal intratesticular T concentration will maintain or initiate spermatogenesis (21, 22) in stalk-sectioned hypophysectomized adult or immature monkeys, T administration sufficient to raise serum concentrations 5-to 10-fold higher than normal adult male levels appear necessary to initiate qualitatively normal, but quantitatively reduced, spermatogenesis (13, 14) .
There was a significant reduction in semen quality before the onset of azoospermia in Ag-treated monkeys. The pert::entages of motile and live sperm were significantly reduced in ejaculates with subnormal sperm counts. Moreover, the net negative surface charge on sperm, an indication of sperm maturation and potential fertilizing capacity (23) , was reduced by Ag infusion. Sperm samples from individual monkeys treated with 25 Jlgjday Ag also had a reduced ability to !1p.netrate hamster oocytes with longer Ag treatment periods. Importantly, T administration did not improve any of these indicators of semen quality. Thus, it was possible to maintain the ejaculatory response with T replacement without increasing the potcrttial fertilizing capacity of the semen.
Sperm undergo significant changes during development and maturation within the testes and epididymis. Many of these chaI"ges occur on the sperm surface and are related to the acquisition of fertilizing capacity (24) (25) (26) (27) . There is an i!1crease in the net surface charge of sperm as they mature in the epididymis and a further increase at the time of ejaculation (9, 23, 28) . A reduced surface negative charge of spermatozoa may be associated with reduced fertilizing capacity (23) . These data coupled with results showing a decline in tb .qbility to penetrate hamster oocytes suggest a signi:ir.e'lt decline in tho. potential fertilizing cepacity of spenn from the oligospermic male treated with Ag.
Based on the work of Tezon et at. (29) , a change in tile surface composition or surface charge of primate sperm would be expected in monkeys treated only with Ag that are steroid deprived, but not with combined Ag and T administratwn. This hypothesis is not supported by our Juta, since'.! shift to a reduced net negative charge on sperm was observed in monkeys treated with Ag alone and Ag and T. However, if the alteration of surface charge reflects reduced steroid hormone levels in the epididymis, the level of T replacement did not provide adequate T levels to the epididymis. Alternatively, a steroid hormone other than T is the active steroid hormone in the epididymis. Another explanation is that the reduced gonadotropin levels affect sperm maturation either directly or indirectly.
The validity of the SPA as a measure of fertilizing capacity is controversial (30, 31) . However, the test dORs monitor a significant aspect of sperm function. Ausmanas and collaborators (30) reported good correlation between the SPA and in vitro fertilization of human oocytes, and Rogers (32) found good correlation between this test and the motility and morphology of sperm. The changes in the SPA test with Ag treatment and alterations in motility and sperm surface chRrge, taken together, suggest that the potential fertilizing capacity of sperm from Ag-treated monkeys is significantly impaired before the onset of azoospermia.
The effects of Ag treatment on testicular histology are dramatic, but reversible. As we reported previously (2), seminiferous tubules from Ag-treated monkeys that become E.zuospermic generally contain only Sertoli cells and a few spermatogonia and spermatocytes. No later stages of spermat.ogenesis were evident. T supplementation did not protect the seminiferous tubules from the effects of the Ag. The atrophy of the tubules, the resultant decrease in testicular volume, and the suppression of spermatogenesis were not influenced by T levels sufficient to maintain the ejaculatory response.
